State of the Art Advanced Heart Failure and Arrhythmia Management: Integrating Devices and Pharmacotherapies
Presented by the Division of Cardiology Department of Medicine School of Medicine University of California University of California, San Francisco San Francisco STATE OF THE ART ADVANCED HEART FAILURE AND ARRHYTHMIA MANAGEMENT: INTEGRATING DEVICES AND PHARMACOTHERAPIES (Formerly Update in Electrocardiography and Arrhythmias) October 27, 2012SATURDAY The Stanford Court COURSE CHAIRS Renaissance Hotel Teresa De Marco, MD San Francisco, CA Professor of Medicine and Surgery R.H. and Jane G. Logan Endowed Chair in Cardiology; Director, Heart Failure and Pulmonary Hypertension; Medical Director, Heart Transplantation University of California, San Francisco Melvin M. Scheinman, MD Professor of Medicine, Emeritus; Walter H. Shorenstein Endowed Chair in Cardiology, University of California, San Francisco Barbara J. Drew, RN, PhD Professor of Nursing and of Medicine, Division of Cardiology, University of California, San Francisco
STATE OF THE ART ADVANCED HEART FAILURE The Stanford Court Renaissance HotelAND ARRHYTHMIA MANAGEMENT: San Francisco, CAINTEGRATING DEVICES ANDPHARMACOTHERAPIES October 27, 2012This one-day symposium is directed to providing an ACCREDITATIONoverview of the salient issues related to assessment and The University of California, San Franciscotreatment of the patient with advanced heart failure. In School of Medicineaddition, since heart failure and cardiac arrhythmias are (UCSF) is accredited byinextricably linked in the management of these patients, the Accreditation Council for Continuing Medicalthe course focuses on the intersection of treatment of Education to providepatients with both conditions. continuing medical education for physicians.There has been a very rapid explosion in the breadth of Physicians:both pharmacologic as well as device related therapies and UCSF designates this liveour main objective will be to review the indications for the activity for a maximum of 8 AMA PRA Category 1myriad pharmacologic as well as device interventions. CreditsTM.Based on previous experience, we have used small group Physicians shouldworkshops to further refine and focus our message to only claim credit commensurate withclinicians with various experiences in the management the extent of theirof these patients. We are very fortunate to have Dr. Kanu participation in the activity.Chatterjee, a world-renowned expert in the area of heart This CME activity meets the requirements underfailure and master clinician, to lecture and lead a panel California Assemblydiscussion related to challenging cases. In addition, Bill 1195, continuingfaculty will include members of the cardiac education and cultural and linguistic competency.electrophysiology and heart failure sections. Nurses: For theThis conference is presented by the Division of Cardiology, purpose of recertification,Department of Medicine, and is sponsored by the Office of the American Nurses Credentialing CenterContinuing Medical Education, University of California, accepts AMA PRASan Francisco. Category 1 CreditsTM issued by organizations. accredited by the ACCME. Physician Assistants:E D U C AT I O N A L O B J E C T I V E S Upon completion of this course, participants should be able to: AAPA accepts AMA PRA • Recognize the indications for anticoagulant therapy for Category 1 CreditsTM patients with atrial fibrillation; for organizations • Discuss the pathophysiologic process leading to the accredited by the development of heart failure with reduced and preserved ACCME. ejection fraction; • Manage advanced heart failure using contemporary pharmacologic and device based approaches; • Define the cardiorenal syndrome in acute heart failure and discuss patient management; • Apply current concepts for indications and patient selection for cardiac resynchronization therapy, implantable cardioverter defibrillator, left ventricular assist devices and heart transplantation in advanced heart failure.
STATE OF THE ART ADVANCED HEART FAILURE AND ARRHINTEGRATING DEVICES AND PHARMACOTH October 27, 2012SATURDAY, OCTOBER 277:30 am Registration and Continental Breakfast8:00 Welcome and Opening Remarks Melvin ScheinmanModerator: Melvin Scheinman8:05 Heart Failure with Preserved EF: How is it Kanu Chatterjee Different from HF with Reduced EF and How Do We Treat it?8:35 Stage C/D Heart Failure with Reduced EF: Liviu Klein Optimal Pharmacotherapy9:10 Atrial Fibrillation in Heart Failure: Rate vs. Vasanth Vedantham Rhythm Control and Role of Newer Anticoagulants9:45 Ventricular Arrhythmias in Heart Failure: Edward Gerstenfeld Pharmacotherapies and Ablation10:15 BreakModerator: Teresa De Marco10:35 Selecting Patients for CRT: Lessons Learned Nitish Badhwar from New Trials11:10 Defining and Treating the Cardiorenal Syndrome Barry Massie in Acute Decompensated Heart Failure11:45 Ventricular Assist Devices to Treat Heart Failure: Dana McGlothlin Indications and Outcomes12:20 pm Course Luncheon and Lifetime Achievement Award for Dr. Kanu ChatterjeeModerator: Barbara Drew1:20 Heart Transplantation Update Teresa De Marco1:55 Concurrent Workshops participants will choose 2 sessions: A: Basic ECG Barbara Drew B: Advanced ECG Nora Goldschlager C: Preventing Re-hospitalization: Disease Nimi Tarango & Management/Heart Failure Monitoring Devices Liviu Klein D: VAD workshop and Case Discussion with Scot Merrick & Live Patient Dana McGlothlin3:05 Concurrent Workshop RepeatModerator: Kanu Chatterjee4:00 Challenging Case Presentations and Byron Lee & Van Selby Panel Discussion Panel: Edmund Keung Dana McGlothlin Scot Merrick Vasanth Vedantham4:45 New Frontiers in Heart Failure Research Robin Shaw5:15 Closing Remarks Melvin Scheinman5:20 pm Adjourn
HYTHMIA MANAGEMENT:ERAPIES The Stanford Court Renaissance Hotel San Francisco, CA GENERAL INFORMATION REFUNDS Pre-registration is preferred to ensure that Refund Policy: Cancellations received in writing adequate course materials are available. before the first day of the course will be refunded, less a $75 administrative fee. No refunds will be HOW TO ENROLL made on cancellations received after that date. Tuition: $200 Physicians CONFERENCE LOCATION $175 Nurses / Allied Health Enjoy San Francisco’s renowned attractions such as Professionals the historic cable cars, shopping in Union Square, Registration fee includes course syllabus, or visit San Francisco’s culinary hub at the Ferry continental breakfast and lunch; additional Building. The Stanford Court Hotel is just steps meals and accommodations are not included. from Union Square. Payment may be made by Visa, MasterCard, A block of guestrooms has been reserved at the AmEx or check. special UCSF discounted conference rate of REGISTER VIA: $224.00 per night, single or double occupancy. Online: www.cme.ucsf.edu The contracted cut-off date is September 28, 2012, or until the group room block is filled, whichever Mail: Complete course registration form comes first. To make hotel reservations on-line, and send with payment to: go to www.stanfordcourt.com use code ELEELEA UCSF Office of CME By staying at the host hotel, you help the P.O. Box 45368 University of California meet its contractual San Francisco, CA 94145-0368 obligations and keep future registration fees Fax: Fax completed registration form to reasonable. Please take this into consideration (415) 502-1795. (Be sure to include when making your accommodation decisions. your credit card number) RENTAL CAR Phone: To register by phone or to inquire about Hertz is offering special rates for participants of this registration status, please call UCSF’s conference; simply call 800-654-2240 and refer to CME Registration Office at (415) 476-5808. identification number #03BW0131, or call your travel agent. You may also make reservations at On-Site Registration (if space allows) www.Hertz.com. Advance reservations are Time: 7:30 am recommended. Date: Saturday, October 27, 2012 AIR TRANSPORTATION UCSF has negotiated special fares with American Place: The Stanford Court Renaissance Hotel and United Airlines for our course attendees. 905 California Street You may use the following tour codes to book San Francisco, CA 94108 on your own: American (800) 433-1790 code: 77H2AZ United (800) 521-4041 code: 510CF Kanu Chatterjee, MB, FRCP was born in Bangladesh and moved to Calcutta as a refugee. He finished his undergraduate medicine education while still living in the refugee camp. He continued his training in England at St. George’s Hospital and Brompton Hospital in London. While at St. George’s Hospital he was the first to describe post pacing T-wave changes which were later termed “cardiac memory”. In collaboration with Drs. Jeremy Swan and William Ganz while faculty cardiologist at Cedar Sinai, Los Angeles, Dr. Chatterjee described the hemodynamic subsets of acute coronary syndrome and proposed therapeutic algorithms. He participated in investigations of cardiogenic shock and made major contributions to the literature. As Director of the Coronary Care Unit at the University of California, San Francisco (UCSF), he pioneered vasodilator therapy for acute and chronic heart failure. He was the first to describe the beneficial effects of sodium nitroprusside in mitral regurgitation. Other major contributions include investigations on the effects of a variety of pharmacologic agents on coronary hemodynamics, myocardial energetics and transmyocardial neurohormonal balance in heart failure and coronary artery disease. Dr. Chatterjee is a gentleman and a scholar who is widely regarded as a gifted teacher and master clinician. He has received many awards including Gifted Teacher Award of ACC, Lifetime Achievement Award by the Heart Failure Society of America, Holly Smith Award for Exceptional Service to School of Medicine at UCSF, Distinguished Scientist Award at University of Iowa, Lewis E. January Clinical Teaching Award, and University of Iowa Legacy Award. He is currently a Clinical Professor of Medicine at the Carver College of Medicine, University of Iowa. He is also Emeritus Professor of Medicine, University of California San Francisco.